Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

about

Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.

P2860

Q49980151-554416FE-EE7D-4C73-858D-5BBB8782E74D

P2860

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

Item

http://www.wikidata.org/entity/Q38835171

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Strategies to control human cy ...... em cell transplant recipients.

@en

type

Item

label

Strategies to control human cy ...... em cell transplant recipients.

@en

prefLabel

Strategies to control human cy ...... em cell transplant recipients.

@en

P1476

Strategies to control human cy ...... tem cell transplant recipients

@en

P2093

Giuseppe Gerna

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex

Vaccine prevention of maternal cytomegalovirus infection

Definitions of cytomegalovirus infection and disease in transplant recipients

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation.

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

P304

1135-1149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2015-0028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniele Lilleri

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27485084

http://www.w3.org/2001/XMLSchema#string

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

about

P2860

P2860

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698